{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:09:12Z","timestamp":1790770152580,"version":"4.1.0"},"reference-count":27,"publisher":"Impact Journals, LLC","issue":"68","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,11,3]]},"DOI":"10.18632\/oncotarget.22367","type":"journal-article","created":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T09:08:10Z","timestamp":1510304890000},"page":"112516-112529","source":"Crossref","is-referenced-by-count":40,"title":["Trends and variations in mantle cell lymphoma incidence from 1995 to 2013: A comparative study between Texas and National SEER areas"],"prefix":"10.18632","volume":"8","author":[{"given":"Shuangshuang","family":"Fu","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Human Genetics, and Environmental Science, School of Public Health, The University of Texas Health Science Center in Houston, Houston, Texas 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Lairson","sequence":"additional","affiliation":[{"name":"Department of Management Policy and Community Health, School of Public Health, The University of Texas Health Science Center in Houston, Houston, Texas 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruosha","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, School of Public Health, The University of Texas Health Science Center in Houston, Houston, Texas 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglin L.","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Human Genetics, and Environmental Science, School of Public Health, The University of Texas Health Science Center in Houston, Houston, Texas 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,11,3]]},"reference":[{"key":"1","unstructured":"Cancer Stat Facts: Non-Hodgkin Lymphoma. Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute. 2017. Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/nhl.html."},{"key":"2","first-page":"3909","article-title":"The Non-Hodgkin's Lymphoma Classification Project","volume":"8","author":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma","year":"1997","journal-title":"Blood"},{"key":"3","first-page":"791","article-title":"Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004","volume":"11","author":"Wang","year":"2008","journal-title":"Cancer"},{"key":"4","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Fourth ed","author":"Vardiman","year":"2008"},{"key":"5","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/ajh.24094","article-title":"Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management","volume":"9","author":"Vose","year":"2015","journal-title":"Am J Hematol"},{"key":"6","first-page":"1677","article-title":"An upward trend in the age-specific incidence patterns for mantle cell lymphoma in the USA","volume":"5","author":"Chiu","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"7","first-page":"637","article-title":"Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data","volume":"1","author":"Jaffe","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"8","first-page":"764","article-title":"Racial differences in mantle cell lymphoma in the United States","volume":"1","author":"Ma","year":"2014","journal-title":"BMC Cancer"},{"key":"9","first-page":"511","article-title":"The co-occurrence of chronic diseases and geriatric syndromes: the health and retirement study","volume":"5","author":"Blaum","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"10","first-page":"391","article-title":"Multiple chronic conditions: prevalence, health consequences, and implications for quality, care management, and costs","volume":"3","author":"Blumenthal","year":"2007","journal-title":"J Gen Intern Med"},{"key":"11","first-page":"S105","article-title":"Disparate inclusion of older adults in clinical trials: priorities and opportunities for policy and practice change","volume":"10","author":"Weinberg","year":"2010","journal-title":"Am J Public Health"},{"key":"12","first-page":"1256","article-title":"Mantle Cell Lymphoma","volume":"3","author":"Wang","year":"2016","journal-title":"J Clin Oncol"},{"key":"13","first-page":"888","article-title":"Gender differences in occupational exposure patterns","volume":"6","author":"Pearce","year":"2011","journal-title":"Occup Environ Med"},{"key":"14","first-page":"57","article-title":"Gender inequalities in occupational health related to the unequal distribution of working and employment conditions: a systematic review","volume":"1","author":"Benavides","year":"2013","journal-title":"Int J Equity Health"},{"key":"15","first-page":"3416","article-title":"Molecular pathogenesis of mantle cell lymphoma","volume":"12","author":"Campo","year":"2012","journal-title":"J Clin Invest"},{"key":"16","first-page":"904","article-title":"Low prevalence of circulating t(11;14)(q13;q32)-positive cells in the peripheral blood of healthy individuals as detected by real-time quantitative PCR","volume":"10","author":"Dolken","year":"2004","journal-title":"Blood"},{"key":"17","first-page":"346","article-title":"Non-Hodgkin's lymphomas with t(11;14)(q13;q32): a subset of mantle zone\/intermediate lymphocytic lymphoma?","volume":"7","author":"Sotto","year":"1991","journal-title":"Br J Haematol"},{"key":"18","first-page":"4867","article-title":"Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma","volume":"2","author":"Shi","year":"2006","journal-title":"J Clin Oncol"},{"key":"19","first-page":"2944","article-title":"Randomized trial of bendamustine-rituximab or R-CHOP\/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study","volume":"12","author":"Clementi","year":"2014","journal-title":"Blood"},{"key":"20","first-page":"716","article-title":"Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1\/2 clinical trial","volume":"1","author":"Newberry","year":"2012","journal-title":"Lancet Oncol"},{"key":"21","first-page":"507","article-title":"Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma","volume":"36","author":"Radford","year":"2013","journal-title":"N Engl J Med"},{"key":"22","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1200\/JCO.2008.20.7977","article-title":"Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma","volume":"2","author":"Hewes","year":"2009","journal-title":"J Clin Oncol"},{"key":"23","first-page":"355","article-title":"Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur","volume":"15","author":"Lauritzsen","year":"2012","journal-title":"Br J Haematol"},{"key":"24","first-page":"1587","article-title":"A phase II multicenter trial of hyperCVAD MTX\/Ara-C and rituximab in patients with previously untreated mantle cell lymphoma; SWOG 0213","volume":"2","author":"Fisher","year":"2013","journal-title":"Ann Oncol"},{"key":"25","unstructured":"Texas. United States Census Bureau. 2015. [cited July 19, 2016]. Available from: http:\/\/www.census.gov\/quickfacts\/table\/PST045215\/48."},{"key":"26","unstructured":"Chapter. Historical background and status of North American standards-Surveillance Epidemiology and End Results Program. North American Association of Central Cancer Registries [cited 10\/24\/2016]. Available from: https:\/\/www.naaccr.org\/Applications\/ContentReader\/Archive\/13\/Chap02.html."},{"key":"27","volume-title":"Regression Analysis of Count Data","author":"Trivedi","year":"1998","edition":"Second"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.22367","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T11:27:51Z","timestamp":1597663671000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.22367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,3]]},"references-count":27,"journal-issue":{"issue":"68","published-print":{"date-parts":[[2017,12,22]]}},"alternative-id":["22367","29348844"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.22367","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,3]]}}}